FAI
ABBV icon

FAI Advisors, Inc.’s AbbVie ABBV Stock Holding History

FAI Advisors, Inc.’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$629K Buy
2,406
+356
+17% +$91.3K 0.24% 78
2026
Q2 		$516K Sell
2,050
-89
-4% -$19.1K 0.2% 90
2026
Q1 		$465K Buy
2,139
+19
+0.9% +$4.22K 0.21% 92
2025
Q4 		$484K Buy
2,120
+120
+6% +$27.3K 0.21% 84
2025
Q3 		$463K Buy
2,000
+85
+4% +$17.3K 0.21% 90
2025
Q2 		$355K Buy
1,915
+244
+15% +$45.3K 0.17% 98
2025
Q1 		$350K Sell
1,671
-84
-5% -$16.3K 0.19% 91
2024
Q4 		$312K Buy
+1,755
New +$323K 0.14% 112

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

FAI Advisors, Inc.'s ABBV Position: Q3 2026 in Review

FAI Advisors, Inc. increased its AbbVie (ABBV) stake by 17% in Q3 2026, buying an estimated $91.3K and bringing the position to 2,406 shares worth $629K. The position accounts for 0.24% of the portfolio, ranked #78.

FAI Advisors, Inc. first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 1,657 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • FAI Advisors, Inc. held 2,406 shares of AbbVie worth $629K as of Q3 2026.
  • FAI Advisors, Inc. bought 356 AbbVie shares in Q3 2026, an estimated $91.3K.
  • AbbVie made up 0.24% of FAI Advisors, Inc.'s portfolio in Q3 2026, its #78 holding.
  • FAI Advisors, Inc. first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 1,657 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on FAI Advisors, Inc.'s 13F filing for Q3 2026, filed 27 Oct 2026.